Live Breaking News & Updates on Development Committee At Celgene

Stay updated with breaking news from Development committee at celgene. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Beam Therapeutics Announces Pipeline and Business Highlights and Reports Second Quarter 2022 Financial Results

09.08.2022 - Patient Enrollment into BEACON Phase 1/2 Trial of BEAM-101 On-track for Second Half of 2022 BEAM-201 IND Submitted to FDA; Currently on Clinical Hold BEAM-102 IND Submission and BEAM-301 IND-enabling Studies On-track for Second Half of 2022 John . ....

United States , United Kingdom , John Evans , Dan Budwick , Astra Zeneca , Chelcie Lister , Beam Therapeutics Inc , Federation Of American Societies For Experimental Biology , Drug Administration , American Society Of Cell , Research Development Rd Expenses , Exchange Commission , Strategic Communications , Development Committee At Celgene , Mckinsey Company , Bristol Myers Squibb , Chief Commercial , Second Quarter , Cash Equivalents , Marketable Securities , Support Advancement , Broad Precision Genetic Medicines , American Society , Gene Therapy , Hepatitisb Virus , American Societies ,